Pharma Equity Group A/S Cl A (PEG) — Capital Reinvestment Ratio

Latest as of December 2012: 0.02x

Pharma Equity Group A/S Cl A (PEG) has a Capital Reinvestment Ratio of 0.02x as of December 2012, meaning it reinvests 0% of its operating cash flow (Dkr25.17 Million) in capital expenditures (Dkr391.00K). See debt-free asset ratio of Pharma Equity Group A/S Cl A to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

Dkr25.17 Million
DKK

Capital Expenditures

Dkr391.00K
DKK

Data as of

Dec 2012
Most recent filing

Annual Capital Reinvestment Ratio for Pharma Equity Group A/S Cl A (None–None)

Year-by-year Capital Reinvestment Ratio for Pharma Equity Group A/S Cl A from None to None. For live market cap and broader valuation context, see Pharma Equity Group A/S Cl A stock valuation.

Year Reinvestment Ratio Operating CF (DKK) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow